Bradley Lunde

Person

Lebanon, NH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 12,129,300
- Issue date Oct 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,939,384
- Issue date Mar 26, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody variable domains targeting the NKG2D receptor
- Patent number 11,884,733
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins binding HER2, NKG2D and CD16
- Patent number 11,884,732
- Issue date Jan 30, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion molecules
- Patent number 10,947,284
- Issue date Mar 16, 2021
- Pieris Pharmaceuticals GmbH
- Carsten Corvey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins specific for pyoverdine and pyochelin
- Patent number 10,329,334
- Issue date Jun 25, 2019
- SANOFI
- Carsten Corvey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion molecules
- Patent number 10,316,071
- Issue date Jun 11, 2019
- Sanofi
- Carsten Corvey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins specific for pyoverdine and pyochelin
- Patent number 10,118,952
- Issue date Nov 6, 2018
- Sanofi
- Carsten Corvey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins specific for pyoverdine and pyochelin
- Patent number 10,072,056
- Issue date Sep 11, 2018
- Sanofi
- Carsten Corvey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins specific for pyoverdine and pyochelin
- Patent number 10,065,998
- Issue date Sep 4, 2018
- Sanofi
- Carsten Corvey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Proteins specific for pyoverdine and pyochelin
- Patent number 9,884,898
- Issue date Feb 6, 2018
- Sanofi
- Carsten Corvey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20250019444
- Publication date Jan 16, 2025
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING HER2, NKG2D AND CD16
- Publication number 20240228625
- Publication date Jul 11, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076385
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240076384
- Publication date Mar 7, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20240067735
- Publication date Feb 29, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING CD123, NKG2D AND CD16
- Publication number 20240018266
- Publication date Jan 18, 2024
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC BINDING PROTEINS TARGETING CEA
- Publication number 20230391877
- Publication date Dec 7, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND NECTIN4
- Publication number 20230357409
- Publication date Nov 9, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230303702
- Publication date Sep 28, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20230227562
- Publication date Jul 20, 2023
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SERUM ALBUMIN ANTIBODIES
- Publication number 20230032087
- Publication date Feb 2, 2023
- Cullinan Oncology, Inc.
- Patrick A. Baeuerle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20220380459
- Publication date Dec 1, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20220153848
- Publication date May 19, 2022
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20220089760
- Publication date Mar 24, 2022
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN
- Publication number 20210363261
- Publication date Nov 25, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...
- Publication number 20210317223
- Publication date Oct 14, 2021
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20210292420
- Publication date Sep 23, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16, AND EGFR, CCR4, OR PD-L1
- Publication number 20210261668
- Publication date Aug 26, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND P-CADHERIN
- Publication number 20210238290
- Publication date Aug 5, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS,...
- Publication number 20210221894
- Publication date Jul 22, 2021
- Dragonfly Therapeutics, Inc.
- Mitchell Bigelow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON
- Publication number 20210214436
- Publication date Jul 15, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20210206859
- Publication date Jul 8, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...
- Publication number 20210198369
- Publication date Jul 1, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC BINDING PROTEINS TARGETING CEA
- Publication number 20210130496
- Publication date May 6, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING CD33, NKG2D AND CD16
- Publication number 20210130471
- Publication date May 6, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC BINDING PROTEINS TARGETING CAIX, ANO1, MESOTHELIN, TR...
- Publication number 20210130474
- Publication date May 6, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...
- Publication number 20210101976
- Publication date Apr 8, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...
- Publication number 20210079102
- Publication date Mar 18, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR
- Publication number 20210054082
- Publication date Feb 25, 2021
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
- Publication number 20200277383
- Publication date Sep 3, 2020
- Dragonfly Therapeutics, Inc.
- Gregory P. Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Bradley Lunde

Person

Patents Grantslast 30 patents

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

Proteins binding HER2, NKG2D and CD16

Fusion molecules

Proteins specific for pyoverdine and pyochelin

Fusion molecules

Proteins specific for pyoverdine and pyochelin

Proteins specific for pyoverdine and pyochelin

Proteins specific for pyoverdine and pyochelin

Proteins specific for pyoverdine and pyochelin

Patents Applicationslast 30 patents

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

PROTEINS BINDING HER2, NKG2D AND CD16

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

PROTEINS BINDING CD123, NKG2D AND CD16

MULTISPECIFIC BINDING PROTEINS TARGETING CEA

PROTEINS BINDING NKG2D, CD16 AND NECTIN4

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

ANTI-SERUM ALBUMIN ANTIBODIES

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

PROTEIN BINDING NKG2D, CD16 AND A FIBROBLAST ACTIVATION PROTEIN

MULTI-SPECIFIC BINDING PROTEINS THAT BIND BCMA, NKG2D AND CD16, AND...

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

PROTEINS BINDING NKG2D, CD16, AND EGFR, CCR4, OR PD-L1

PROTEINS BINDING NKG2D, CD16 AND P-CADHERIN

PROTEINS BINDING NKG2D, CD16 AND AN ANTIGEN ASSOCIATED WITH TUMORS,...

MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN

MULTI-SPECIFIC BINDING PROTEINS THAT BIND HER2, NKG2D, AND CD16, AN...

MULTISPECIFIC BINDING PROTEINS TARGETING CEA

PROTEINS BINDING CD33, NKG2D AND CD16

MULTISPECIFIC BINDING PROTEINS TARGETING CAIX, ANO1, MESOTHELIN, TR...

MULTI-SPECIFIC BINDING PROTEINS THAT BIND CD33, NKG2D, AND CD16, AN...

COMBINATION THERAPY OF CANCER INVOLVING MULTI-SPECIFIC BINDING PROT...

ANTIBODY VARIABLE DOMAINS TARGETING THE NKG2D RECEPTOR

PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN